FDA Sees Need For New Payment Models To Help Antibiotic Development.

Congressional Quarterly (9/14, Siddons, Subscription Publication) reported FDA Commissioner Scott Gottlieb said Friday that the agency is “discussing reimbursement approaches with public and private insurers that could help drug companies develop antibio...